Publication Information

{'id': 'https://openalex.org/W2121496639', 'doi': 'https://doi.org/10.2337/diabetes.50.2.411', 'title': 'Peroxisome Proliferator—Activated Receptor (PPAR)-αActivation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats', 'display_name': 'Peroxisome Proliferator—Activated Receptor (PPAR)-αActivation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats', 'publication_year': 2001, 'publication_date': '2001-02-01', 'ids': {'openalex': 'https://openalex.org/W2121496639', 'doi': 'https://doi.org/10.2337/diabetes.50.2.411', 'mag': '2121496639', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11272155'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2337/diabetes.50.2.411', 'pdf_url': 'https://diabetesjournals.org/diabetes/article-pdf/50/2/411/646803/0500411.pdf', 'source': {'id': 'https://openalex.org/S129060628', 'display_name': 'Diabetes', 'issn_l': '0012-1797', 'issn': ['0012-1797', '1939-327X'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320274', 'host_organization_name': 'American Diabetes Association', 'host_organization_lineage': ['https://openalex.org/P4310320274'], 'host_organization_lineage_names': ['American Diabetes Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://diabetesjournals.org/diabetes/article-pdf/50/2/411/646803/0500411.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5004673580', 'display_name': 'Ji‐Ming Ye', 'orcid': 'https://orcid.org/0000-0003-3983-0098'}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'Ji-Ming Ye', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111446830', 'display_name': 'Patrick J. Doyle', 'orcid': 'https://orcid.org/0009-0004-5001-933X'}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'Patrick J. Doyle', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101462128', 'display_name': 'Miguel A. Iglesias', 'orcid': 'https://orcid.org/0000-0001-5781-2091'}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'Miguel A. Iglesias', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069174970', 'display_name': 'David G. Watson', 'orcid': 'https://orcid.org/0000-0003-1094-7604'}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'David G. Watson', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103260758', 'display_name': 'Gregory J. Cooney', 'orcid': 'https://orcid.org/0000-0003-0012-2529'}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'Gregory J. Cooney', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5113708554', 'display_name': 'Edward W. Kraegen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189090001', 'display_name': 'Novo Nordisk (Denmark)', 'ror': 'https://ror.org/0435rc536', 'country_code': 'DK', 'type': 'funder', 'lineage': ['https://openalex.org/I189090001', 'https://openalex.org/I2801134892', 'https://openalex.org/I4210159963']}, {'id': 'https://openalex.org/I136750679', 'display_name': 'Garvan Institute of Medical Research', 'ror': 'https://ror.org/01b3dvp57', 'country_code': 'AU', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I136750679', 'https://openalex.org/I4210087284']}], 'countries': ['AU', 'DK'], 'is_corresponding': False, 'raw_author_name': 'Edward W. Kraegen', 'raw_affiliation_strings': ['From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.'], 'affiliations': [{'raw_affiliation_string': 'From the Garvan Institute of Medical Research (J.-M.Y., M.A.I., D.G.W.,G.J.C., E.W.K.), Sydney, Australia; and Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001', 'https://openalex.org/I136750679']}, {'raw_affiliation_string': 'Novo Nordisk A/S (P.J.D.), Bagsverd,Denmark.', 'institution_ids': ['https://openalex.org/I189090001']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 9.873, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 350, 'citation_normalized_percentile': {'value': 0.999976, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '50', 'issue': '2', 'first_page': '411', 'last_page': '417'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11457', 'display_name': 'Adipose Tissue and Metabolism', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10528', 'display_name': 'Adipokines, Inflammation, and Metabolic Diseases', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.73200816}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.7163081}, {'id': 'https://openalex.org/C187345961', 'wikidata': 'https://www.wikidata.org/wiki/Q419629', 'display_name': 'Peroxisome proliferator-activated receptor', 'level': 3, 'score': 0.7022677}, {'id': 'https://openalex.org/C3017594256', 'wikidata': 'https://www.wikidata.org/wiki/Q1053470', 'display_name': 'Insulin sensitivity', 'level': 4, 'score': 0.68306345}, {'id': 'https://openalex.org/C127078168', 'wikidata': 'https://www.wikidata.org/wiki/Q138639', 'display_name': 'Peroxisome', 'level': 3, 'score': 0.55763406}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.54325444}, {'id': 'https://openalex.org/C2777391703', 'wikidata': 'https://www.wikidata.org/wiki/Q1053470', 'display_name': 'Insulin resistance', 'level': 3, 'score': 0.49100426}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.44880444}, {'id': 'https://openalex.org/C130241916', 'wikidata': 'https://www.wikidata.org/wiki/Q20970208', 'display_name': 'Peroxisome proliferator-activated receptor gamma', 'level': 4, 'score': 0.43679518}, {'id': 'https://openalex.org/C2779306644', 'wikidata': 'https://www.wikidata.org/wiki/Q2002370', 'display_name': 'Insulin', 'level': 2, 'score': 0.4180316}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.29065257}], 'mesh': [{'descriptor_ui': 'D004041', 'descriptor_name': 'Dietary Fats', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D007333', 'descriptor_name': 'Insulin Resistance', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D050356', 'descriptor_name': 'Lipid Metabolism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D018482', 'descriptor_name': 'Muscle, Skeletal', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D018160', 'descriptor_name': 'Receptors, Cytoplasmic and Nuclear', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D014157', 'descriptor_name': 'Transcription Factors', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004041', 'descriptor_name': 'Dietary Fats', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004041', 'descriptor_name': 'Dietary Fats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005947', 'descriptor_name': 'Glucose', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005947', 'descriptor_name': 'Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015309', 'descriptor_name': 'Glucose Clamp Technique', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006946', 'descriptor_name': 'Hyperinsulinism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006946', 'descriptor_name': 'Hyperinsulinism', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D007333', 'descriptor_name': 'Insulin Resistance', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018482', 'descriptor_name': 'Muscle, Skeletal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017208', 'descriptor_name': 'Rats, Wistar', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018160', 'descriptor_name': 'Receptors, Cytoplasmic and Nuclear', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012016', 'descriptor_name': 'Reference Values', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014157', 'descriptor_name': 'Transcription Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2337/diabetes.50.2.411', 'pdf_url': 'https://diabetesjournals.org/diabetes/article-pdf/50/2/411/646803/0500411.pdf', 'source': {'id': 'https://openalex.org/S129060628', 'display_name': 'Diabetes', 'issn_l': '0012-1797', 'issn': ['0012-1797', '1939-327X'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320274', 'host_organization_name': 'American Diabetes Association', 'host_organization_lineage': ['https://openalex.org/P4310320274'], 'host_organization_lineage_names': ['American Diabetes Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11272155', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2337/diabetes.50.2.411', 'pdf_url': 'https://diabetesjournals.org/diabetes/article-pdf/50/2/411/646803/0500411.pdf', 'source': {'id': 'https://openalex.org/S129060628', 'display_name': 'Diabetes', 'issn_l': '0012-1797', 'issn': ['0012-1797', '1939-327X'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320274', 'host_organization_name': 'American Diabetes Association', 'host_organization_lineage': ['https://openalex.org/P4310320274'], 'host_organization_lineage_names': ['American Diabetes Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 48, 'referenced_works': ['https://openalex.org/W1485967434', 'https://openalex.org/W1553080809', 'https://openalex.org/W1647126819', 'https://openalex.org/W1763805809', 'https://openalex.org/W1776131825', 'https://openalex.org/W1778141833', 'https://openalex.org/W1827694047', 'https://openalex.org/W1969478165', 'https://openalex.org/W1971617514', 'https://openalex.org/W1979761686', 'https://openalex.org/W1980662936', 'https://openalex.org/W1981101682', 'https://openalex.org/W1985683101', 'https://openalex.org/W1992527366', 'https://openalex.org/W2000312245', 'https://openalex.org/W2003755391', 'https://openalex.org/W2012898950', 'https://openalex.org/W2027874598', 'https://openalex.org/W2037520352', 'https://openalex.org/W2043106623', 'https://openalex.org/W2060627716', 'https://openalex.org/W2065624367', 'https://openalex.org/W2074545234', 'https://openalex.org/W2075408008', 'https://openalex.org/W2076898686', 'https://openalex.org/W2078535741', 'https://openalex.org/W2084470550', 'https://openalex.org/W2097753436', 'https://openalex.org/W2099110187', 'https://openalex.org/W2102434966', 'https://openalex.org/W2102603465', 'https://openalex.org/W2116211046', 'https://openalex.org/W2119091648', 'https://openalex.org/W2121309304', 'https://openalex.org/W2125344994', 'https://openalex.org/W2129803878', 'https://openalex.org/W2137046761', 'https://openalex.org/W2144315650', 'https://openalex.org/W2147627625', 'https://openalex.org/W2157159658', 'https://openalex.org/W2225395848', 'https://openalex.org/W2762569982', 'https://openalex.org/W4234783941', 'https://openalex.org/W4235189018', 'https://openalex.org/W4242246289', 'https://openalex.org/W4246501628', 'https://openalex.org/W4254025868', 'https://openalex.org/W4255038910'], 'related_works': ['https://openalex.org/W4255460549', 'https://openalex.org/W4245484926', 'https://openalex.org/W4245196542', 'https://openalex.org/W4244946154', 'https://openalex.org/W4239990314', 'https://openalex.org/W4238848915', 'https://openalex.org/W4230283928', 'https://openalex.org/W3087994600', 'https://openalex.org/W2476333924', 'https://openalex.org/W2094095902'], 'abstract_inverted_index': {'Peroxisome': [0], 'proliferator—activated': [1], 'receptor': [2], '(PPAR)-α': [3], 'agonists': [4], 'lower': [5], 'circulating': [6], 'lipids,': [7], 'but': [8], 'the': [9, 33, 49, 55, 66, 200, 247, 261], 'consequences': [10], 'for': [11, 65], 'muscle': [12, 90, 153, 160, 177, 189, 194, 234, 243, 267], 'lipid': [13, 235, 268], 'metabolism': [14], 'and': [15, 31, 85, 88, 111, 125, 138, 140, 144, 158, 162, 209, 225, 228, 255], 'insulin': [16, 26, 130, 178, 244, 253], 'sensitivity': [17, 27, 131], 'are': [18], 'not': [19], 'clear.': [20], 'We': [21, 219], 'investigated': [22], 'whether': [23], 'PPAR-αactivation': [24], 'improves': [25], 'in': [28, 246], 'insulin-resistant': [29], 'rats': [30, 43], 'compared': [32], 'effects': [34, 173], 'with': [35, 48, 183, 199, 210], 'PPAR-γ': [36, 56, 229], 'activation.': [37], 'Three-week': [38], 'high': [39, 248], 'fat-fed': [40], 'male': [41], 'Wistar': [42], 'were': [44], 'untreated': [45], 'or': [46, 54], 'treated': [47], 'specific': [50], 'PPAR-α': [51, 227], 'agonist': [52, 57], 'WY14643': [53, 75, 105, 124, 175, 224], 'pioglitazone': [58, 126, 169], '(both': [59], '3': [60], 'mg': [61], '·': [62], 'kg-1·': [63], 'day-1)': [64], 'last': [67], '2': [68], 'weeks': [69], 'of': [70, 80, 202, 252], 'high-fat': [71], 'feeding.': [72], 'Like': [73], 'pioglitazone,': [74, 104], 'lowered': [76], 'basal': [77], 'plasma': [78, 211], 'levels': [79, 213], 'glucose,': [81], 'triglycerides(-16%': [82], 'vs.': [83, 147], 'untreated),': [84], 'leptin': [86], '(-52%),': [87], 'also': [89], 'triglyceride': [91, 114, 161, 212], '(-34%)and': [92], 'total': [93, 112], 'long-chain': [94], 'acyl-CoAs': [95], '(LCACoAs)': [96], '(-41%)': [97], '(P': [98, 116, 165], '<': [99, 117, 166], '0.05).': [100, 167], 'In': [101], 'contrast': [102], 'to': [103, 187, 260, 263], 'substantially': [106], 'reduced': [107, 159], 'visceral': [108], 'fat': [109], 'weight': [110, 122], 'liver': [113], 'content': [115, 201], '0.01)': [118], 'without': [119], 'increasing': [120], 'body': [121], 'gain.': [123], 'similarly': [127], 'enhanced': [128, 151], 'wholebody': [129], '(clamp': [132], 'glucose': [133, 141, 154], 'infusion': [134], 'rate': [135], 'increased': [136], '35': [137], '37%': [139], 'disposal': [142], '22': [143], '15%,': [145], 'respectively,': [146, 231], 'untreated).': [148], 'Both': [149], 'agents': [150], 'insulin-mediated': [152, 193], 'metabolic': [155], 'index': [156], "(Rg')": [157], 'LCACoA': [163, 190], 'accumulation': [164], 'Although': [168], 'had': [170], 'more': [171], 'potent': [172], 'than': [174], 'on': [176], 'sensitization,': [179], 'this': [180, 256], 'was': [181, 196], 'associated': [182], 'its': [184], 'greater': [185], 'effect': [186, 257], 'reduce': [188, 266], 'accumulation.': [191, 269], 'Overall': [192], "Rg'": [195], 'inversely': [197], 'correlated': [198], 'LCACoAs': [203], '(r': [204, 214], '=': [205, 215], '-0.74,': [206], 'P': [207], '=0.001)': [208], '-0.77,': [216], 'P<': [217], '0.001).': [218], 'conclude': [220], 'that': [221], 'even': [222], 'though': [223], 'pioglitazone,representing': [226], 'activation,': [230], 'may': [232], 'alter': [233], 'supply': [236], 'by': [237], 'different': [238], 'mechanisms,': [239], 'both': [240], 'significantly': [241], 'improve': [242], 'action': [245], 'fat—fed': [249], 'rat': [250], 'model': [251], 'resistance,': [254], 'is': [258], 'proportional': [259], 'degree': [262], 'which': [264], 'they': [265]}, 'abstract_inverted_index_v3': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2121496639', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 12}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 11}, {'year': 2016, 'cited_by_count': 6}, {'year': 2015, 'cited_by_count': 12}, {'year': 2014, 'cited_by_count': 14}, {'year': 2013, 'cited_by_count': 15}, {'year': 2012, 'cited_by_count': 14}], 'updated_date': '2025-01-26T20:57:36.075098', 'created_date': '2016-06-24'}